Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy
Background: Metabolic cancers are defined by metabolic reprogramming. Although this reprograming drives rapid tumour growth and invasion, it also reveals specific metabolic vulnerabilities that can be therapeutically exploited in cancer therapy. A novel form of programmed cell death, known as disulf...
Saved in:
| Main Authors: | Xinyan Li, Jiayi Xu, Liangwen Yan, Shenkang Tang, Yinggang Zhang, Mengjiao Shi, Pengfei Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/14/11/604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The characteristics and functional significance of disulfidptosis-related genes in head and neck squamous cell carcinoma
by: Haiqian Zhu, et al.
Published: (2024-12-01) -
Metabolic reprogramming in lung cancer and its clinical implication
by: Qingqiu Huang, et al.
Published: (2024-12-01) -
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
by: Kun Huang, et al.
Published: (2025-01-01) -
Targeting KRAS: from metabolic regulation to cancer treatment
by: Yanyan Shi, et al.
Published: (2025-01-01) -
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
by: Kai Wang, et al.
Published: (2025-02-01)